Facebook Join My List Logo
American Society of Interventional Pain Physicians | September 11, 2019
Inaugural Midsouth Meeting in Memphis Next Week! –Register Today!
 
We invite you to the first meeting of the Midsouth Societies of Interventional Pain Physicians September 20-22 in Memphis at the Historic Peabody Hotel.
 
IPM: Issues, Pitfalls and Opportunities is for physicians and midlevel practitioners for the following states: Alabama, Arkansas, Indiana, Kentucky, Mississippi, Missouri, and Tennessee.
 
The meeting will address regulatory aspects of opioid therapies while also bringing in the DEA’s perspective. Learn about advances in the field and bring your staff for sessions on billing and coding and denials and appeals.
 
CATEGORY I CREDIT
The Institute for Medical Studies designates the Midsouth 2019 Annual Meeting live activity for a
maximum of 17 AMA PRA Category 1 Credits™ .
 
Click here for meeting registration.
 
Click Below to view:
Join the AMA to help us keep our seat in the House of Delegates

The American Medical Association (AMA) requires all societies to requalify for membership in the AMA House of Delegates (HOD) every five years. In order for ASIPP to retain our seat, the AMA requires that 20% of ASIPP’s physician members also be members of the AMA. Unfortunately, ASIPP is at risk of losing representation in the AMA because we have fallen below the 20% membership minimum threshold.

Membership in the AMA gives us a voice in shaping policy that affects our practice and patients.
We encourage you to join or renew your membership in the AMA. Joining the AMA will further strengthen our specialty’s representation at the national level through the AMA House of Delegates, the AMA’s policymaking body, and strengthen our ability to meet the challenges in health care today with thoughtful, well-organized responses.

We strongly encourage you to join the AMA today to help us keep our seat at the table. Right now, you can become a member and pay only half the dues.

The stronger our membership, the more we can advance issues that are important to our specialty including improving the Medicare Quality Payment Program, reducing administrative burdens and ensuring accurate coding and reimbursement of our services.

Thank you for supporting ASIPP!

Click HERE to join today and pay only half price! 
Number of Uninsured Americans Rises for First Time in Decade
Increase is largely driven by a decline in coverage under public programs such as Medicaid

The number of Americans without health insurance climbed to 27.5 million in 2018, according to federal data that show the first year-to-year increase in a decade, before the Affordable Care Act began reducing the ranks of the uninsured.

The increase, which follows years of steady declines in the number of uninsured, appears to have been driven by a decline in coverage under public health programs such as Medicaid, according to the report. The number of uninsured rose by nearly two million people overall, the Census Bureau said, which is about how many fewer people were covered under Medicaid compared with 2017. The number of people covered by private insurance didn’t significantly change.

The 27.5 million people without health coverage represents 8.5% of Americans, up from 7.9%, or 25.6 million people, in 2017, according to the census data. The percentage increase is the first since one from 2008 to 2009.


Access to this article may be limited.

JUNE 2020 ABIPP EXAMS
AND COMPETENCY EXAMS
June 13 - June 14, 2020 | Memphis, TN
 
The American Board of Interventional Pain Physicians ( ABIPP ) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management
profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become ABIPP certified.
ABIPP now offers the only competency certification program for regenerative medicine.
 
For complete information about the examination requirements and to obtain an application packet, visit www.abipp.org or call 270-554-9412 x4217 or by email at summer@asipp.org.
 
June 13
ABIPP Part I  
Combined CSM/CCPM Exam for ABIPP Path
Competency Exam in Controlled Substance Management
Competency Exam in Coding, Compliance, and
Practice Management

June 13-14
ABIPP Part II  
Regenerative Medicine Competency Exam
Endoscopic Lumbar Decompression Competency Exam

June 14
ABIPP Competency Exam


939 Ridge Lake Blvd. | Memphis, TN 38120
 
Opioid crackdown forces pain patients to taper off drugs they say they need

Carol and Hank Skinner of Alexandria, Va., can talk about pain all day long.
Carol, 77, once had so much pain in her right hip and so little satisfaction with medical treatment she vowed to stay in bed until she died.
Hank, 79, has had seven shoulder surgeries, lung cancer, open-heart surgery, a blown-out knee and lifelong complications from a clubfoot. He has a fentanyl patch on his belly to treat his chronic shoulder pain. He replaces the patch every three days, supplementing the slow-release fentanyl with pills containing hydrocodone.
But to the Skinners’ dismay, Hank is now going through what is known as a forced taper. That’s when a chronic pain patient has to switch to a lower dosage of medication. His doctor, Hank says, has cut his fentanyl dosage by 50 percent — and Hank’s not happy about it. He already struggles to sleep through the night, as Carol can attest.


CMS pitches sweeping changes to rules for maintaining Medicare billing privileges
 
CMS' proposed 2020 Medicare Physician Fee Schedule includes substantial changes to the rules for obtaining and maintaining Medicare billing privileges.

A one-paragraph statement in the proposed rule calls for applying Medicare enrollment approval and revocation rules for opioid treatment programs to all physicians and other eligible professionals. The proposal would allow CMS to revoke Medicare billing privileges for physicians, advance practice nurses and others for a variety of reasons, according to law firm Baker Donelson.  

If finalized, the rule would allow CMS to revoke the Medicare billing privileges of any physician who has "been subject to prior action from a state oversight board, federal or state health care program, Independent Review Organization (IRO) determination(s), or any other equivalent governmental body or program that oversees, regulates, or administers the provision of healthcare with underlying facts reflecting improper physician or other eligible professional conduct that led to patient harm."
 

America's Deadliest Drug: Fentanyl | Patriot Act with Hasan Minhaj | Netflix

Published on Aug 12, 2019

On the latest episode of Patriot Act, Hasan discusses America’s opioid epidemic and the recent spike in deaths due to one drug in particular: fentanyl. One of the most powerful drugs ever created, Fentanyl is a highly potent opiate that’s now the leading cause of overdose deaths in the United States. Hasan looks into its makers and distributors, from cartels to pharmaceutical companies like Insys and Teva, to discern how it has been able to wreak so much havoc on so many lives.


Interventional Pain Management Reports is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine. 

Interventional Pain Management Reports is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of Pain Physician . Interventional Pain Management Reports Interventional Pain Management Reports is an open access journal, available online with free full manuscripts.  

The benefits of publishing in an open access journal that has a corresponding
print edition journal are:  
  • Your article will have the potential to obtain more citations.
  • Your article will be peer-reviewed and published faster than other journals.
  • Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.  
  • Open Access journals are FREE to view, download and to print.

So submit today your:
  • Case Reports
  • Technical Reports
  • Editorials
  • Short Perspectives

2019 MIPS Reporting? Start Now.
MIPS-eligible clinicians must report a full year of data. Don’t fall behind – keep up with NIPM-QCDR.
 
MIPS 2019 has brought larger payment adjustments and greater reporting requirements, including a 365-day performance period for the Quality and Cost categories. The sooner you start your MIPS reporting for 2019, the better.
Sign up today to use ASIPP’s NIPM-QCDR for MIPS.
This powerful tool makes MIPS reporting easy through the use of our new patient-reported outcomes measures for 2019, which ease the burden on providers and reduces costly EMR integration.

Get started today at ASIPP.ArborMetrix.net

Today’s medicine is not the medicine I signed up for

Today’s medicine is not the medicine I signed up for. I am a Xennial. Sandwiched between generation X and millennials, I don’t really belong to either. I didn’t grow up with the technological advancements that the millennial generation enjoy. I grew up with corded telephones, large box televisions, and without a computer in the house. We played in the streets until dark with the neighborhood kids and played board games instead of video games. I didn’t grow up with social media or Wikipedia, although in my later teenage years was quick to adapt to the technology that is now commonplace. I have enjoyed an analog childhood and a digital adulthood.

I am also from a Xennial generation of medicine. Medicine was different when I started. I entered medicine in a world where providers were respected, when the majority of physicians were in private practice and had autonomy over their schedule and their practice. I entered medicine when the electronic medical record wasn’t even a phrase. I have witnessed an evolution in medicine. I have watched medicine change.


Britain facing its own opioid crisis with middle-aged women fuelling 60 per cent rise in prescriptions

Britain is in the grip of a growing opioid crisis, with middle-aged women fuelling a 60 per cent rise in the numbers of heavy painkillers, anxiety medications and antidepressants prescribed in the last decade.
Medics warned that the trends show the situation in the UK could become “devastating” - aping an epidemic seen in the US.

The Sunday Telegraph can reveal that 141 million prescriptions were issued for such drugs last year - a rise from 89 million in 2008.

The statistics show a doubling in the number of antidepressants issued, while prescribing of painkillers containing opioids has risen by more than a fifth.


CMS targets healthcare providers' affiliates in new rule
 
The CMS will be able to revoke healthcare providers or suppliers' Medicare enrollment if they are affiliated with targeted "bad actors," a final rule issued Wednesday established.

As part of the CMS' " Program Integrity Enhancements to the Provider Enrollment Process " going into effect Nov. 4, its new "affiliations" provision allows authorities to bar individuals and organizations that "pose an undue risk of fraud, waste or abuse based on their relationships with other sanctioned entities."
Medicare, Medicaid and CHIP providers will have to disclose any current or previous affiliation with an organization that has uncollected debt, has had a payment suspension under a federal healthcare program, has been excluded from those programs, or has had billing privileges denied or rescinded.


Longitudinal Low Density Lipoprotein Cholesterol Goal Achievement and Cardiovascular Outcomes Among Adult Patients with Familial Hypercholesterolemia: The CASCADE FH registry

BACKGROUND AND AIMS:
There are limited data from the US on outcomes of patients in specialty care for familial hypercholesterolemia (FH).

METHODS:
CASCADE FH Registry data were analyzed to assess longitudinal changes in medication usage, in low density lipoprotein cholesterol (LDL-C) levels, and the rate of major adverse cardiovascular events (MACE (myocardial infarction, coronary revascularization, stroke or transient ischemic attack) in adults with FH followed in US specialty clinics.

RESULTS:
The cohort consisted of 1900 individuals (61% women, 87% Caucasian), with mean age of 56 ± 15 years, 37% prevalence of ASCVD at enrollment, mean pretreatment LDL-C 249 ± 68 mg/dl, mean enrollment LDL-C 145 mg/dl and 93% taking lipid lowering therapy. Over follow up of 20 ± 11 months, lipid lowering therapy use increased (mean decrease in LDL-C of 32 mg/dl (p < 0.001)). Only 48% of participants achieved LDL-C < 100 mg/dl and 22% achieved LDL-C < 70 mg/dl; ASCVD at enrollment was associated with greater likelihood of goal achievement. MACE event rates were almost 6 times higher among patients with prior ASCVD compared to those without (4.6 vs 0.8/100 patient years). Also associated with incident MACE were markers of FH severity and conventional ASCVD risk factors.

CONCLUSIONS:
With care in FH specialized clinics, LDL-C decreased, but LDL-C persisted >100 mg/dl in 52% of patients. High ASCVD event rates suggest that adults with FH warrant designation as having an ASCVD risk equivalent. Earlier and more aggressive therapy of FH is needed to prevent ASCVD events.


CDC: January to July 2018 Saw Decrease in Opioid-Involved Overdose Deaths

HealthDay News — Opioid deaths decreased during January to July 2018, while deaths from illicitly manufactured fentanyl (IMF) increased during the same period, according to research published in the Aug. 30 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report .

Noting that provisional estimates of the number of opioid deaths for 2018 suggest a decrease from 2017, R. Matt Gladden, Ph.D., from the CDC in Atlanta, and colleagues evaluated the extent to which the decreases occurred broadly or were limited to specific opioid types. Opioid deaths during January to June 2018 and changes from July to December 2017 were examined in 25 states.


US Surgeon General Warns of Marijuana’s Effect on the Developing Brain

HealthDay News — Marijuana use is risky for young people and pregnant women, a U.S. Surgeon General health advisory warns.

The latest research shows that marijuana is particularly harmful to developing brains and can be passed along to infants in the womb or through breast milk, U.S. Surgeon General Jerome Adams said Thursday, ABC News reported.

Adams said he was deeply concerned about what he called the “rapid normalization” of marijuana and the mistaken belief among young people that because the drug is now legal in some states, it must be safe. “Not enough people [know] that today’s marijuana is far more potent than in days past,” Adams said, ABC News reported.

Kentucky Hospitals Sue Opioid Makers

A group of Kentucky hospitals is suing dozens of opioid makers and distributors saying the companies misrepresented the benefits and dangers of the painkiller.
The complaint filed in Warren County Circuit Court in south-central Kentucky includes hospitals in Bowling Green, Pikeville, Madisonville and several county hospitals.
The civil suit, filed late last month, alleges that the opioid epidemic has forced hospitals to add services, hire additional security and provide increased training to staff. It names OxyContin maker Purdue Pharma, Johnson & Johnson, Walmart and other producers and sellers of the drugs.



State Society News 
October 25-27, 2019
CalSIPP

California Society of Interventional Pain Physicians 10 th annual meeting
The Resort at Squaw Creek, Lake Tahoe.
 



Send in your state society meeting news to Holly Long, hlong@asipp.org
ASIPP | Pain Physician Journal | Phone | Fax | Email